Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma
Spindler, Karen-Lise G., Sorensen, Morten M., Pallisgaard, Niels, Andersen, Rikke F., Havelund, Birgitte M., Ploen, John, Lassen, Ulrik, Jakobsen, Anders K. M.Volume:
52
Language:
english
Journal:
Acta Oncologica
DOI:
10.3109/0284186X.2013.776175
Date:
June, 2013
File:
PDF, 181 KB
english, 2013